Ogbunude P O, Gati W P, Paterson A R
Biochem Pharmacol. 1984 Nov 15;33(22):3561-6. doi: 10.1016/0006-2952(84)90137-0.
HeLa cells as well as human and mouse erythrocytes possess membrane sites which bind the inhibitor of nucleoside transport, nitrobenzylthioinosine (NBMPR), reversibly but tightly (KD, 10(-9)-10(-10) M). Site-specific binding of the ligand correlates with inhibition of nucleoside transport. The present study showed that the 5'-phosphate of NBMPR, NBMPR-P, was not transport inhibitory. Upon exposure to [35S]NBMPR-P or [G-3H]NBMPR-P, HeLa cells retained the isotopic labels virtually exclusively in the form of NBMPR. The dephosphorylation of [G-3H]NBMPR-P by HeLa cells, assayed by the production of extracellular [G-3H]NBMPR, was competitively inhibited by AMP, but was not affected by the presence of 5 microM NBMPR, a concentration sufficient to completely occupy the transport inhibitory sites. Thus, the sites at which dephosphorylation of NBMPR occurs in HeLa cells are separate from and function independently of the high affinity sites which bind NBMPR.
HeLa细胞以及人和小鼠红细胞具有可与核苷转运抑制剂硝基苄硫肌苷(NBMPR)可逆且紧密结合(解离常数KD为10⁻⁹ - 10⁻¹⁰ M)的膜位点。配体的位点特异性结合与核苷转运抑制相关。本研究表明,NBMPR的5'-磷酸酯NBMPR-P没有转运抑制作用。用[³⁵S]NBMPR-P或[G-³H]NBMPR-P处理HeLa细胞后,细胞几乎仅以NBMPR的形式保留同位素标记。通过细胞外[G-³H]NBMPR的产生来检测HeLa细胞对[G-³H]NBMPR-P的去磷酸化作用,结果显示该过程受到AMP的竞争性抑制,但不受5 μM NBMPR存在的影响,5 μM NBMPR的浓度足以完全占据转运抑制位点。因此,HeLa细胞中NBMPR发生去磷酸化的位点与结合NBMPR的高亲和力位点是分开的,且功能独立。